Merck: Better Times Ahead On Approvals And Outlook (NYSE:MRK)

Merck & Co. headquarters in Silicon Valley

Sundry Photography

One of the biggest pharmaceutical stocks by market capitalization, Merck & Co., Inc. (NYSE:MRK) has had a good first quarter at the stock markets in 2024. Its price is up by over 20% after a forgettable 2023

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *